COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF GLYCOPYRRONIUM BROMIDE VERSUS TIOTROPIUM BROMIDE AS A MAINTENANCE BRONCHODILATOR TREATMENT IN PATIENTS WITH MODEREATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

被引：0

作者：

Ruiz Miranda, C., I ^{[1
]}

Ubiarco Lopez, V ^{[1
]}

Chavez Plascencia, E. ^{[1
]}

机构：

[1] Novartis Mexico, Mexico City, DF, Mexico

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRS28

引用

页码：A174 / A174

页数：1

共 50 条

[21] Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
Natalie J. Carter
Drugs, 2013, 73 : 741 - 753
[22] Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
Carter, Natalie J.
DRUGS, 2013, 73 (07) : 741 - 753
[23] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease Australian, Canadian and Swedish Healthcare Perspectives
Mittmann, Nicole
Hernandez, Paul
Mellstrom, Carl
Brannman, Lance
Welte, Tobias
PHARMACOECONOMICS, 2011, 29 (05) : 403 - 414
[24] Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy
O. Zaniolo
S. Iannazzo
L. Pradelli
M. Miravitlles
The European Journal of Health Economics, 2012, 13 : 71 - 80
[25] Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy
Zaniolo, O.
Iannazzo, S.
Pradelli, L.
Miravitlles, M.
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (01): : 71 - 80
[26] Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease
Rodríguez-Carballeira, M
Heredia, JL
Gomez, L
Quintana, S
Vinas, C
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (01) : 43 - 48
[27] Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
Oskar Eklund
Faraz Afzal
Fredrik Borgström
Cost Effectiveness and Resource Allocation, 13
[28] Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
Eklund, Oskar
Afzal, Faraz
Borgstrom, Fredrik
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
[29] Inhaled glycopyrronium bromide: A guide to its use in moderate to severe chronic obstructive pulmonary disease
Lyseng-Williamson K.A.
Carter N.J.
Drugs & Therapy Perspectives, 2013, 29 (12) : 367 - 372
[30] COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN SPAIN
Brosa, M.
Diaz, S.
Miravitlles, M.
Gonzalez-Rojas, N.
Nieves, D.
VALUE IN HEALTH, 2009, 12 (07) : A302 - A302

← 1 2 3 4 5 →